Claudia Romagnoni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Claudia Romagnoni has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Guido Gelpi
Department of Cardiothoracic Surgery, IRCCS Cà Granda Ospedale Maggiore Policlinico di Milano, 20122 Milano, Italy
2 shared publications - Alessandro Parolari
Unit of Cardiac Surgery and Translational Research, IRCCS Policlinico S. Donato, University of Milan, Milan, Italy
1 shared publication - Antonio Giovanni Cammardella
Department of Cardiac Surgery and Heart Transplantation San Camillo Forlanini Hospital of Rome Rome Italy
1 shared publication - Fabio Barili
Università Degli Studi Di Milano, Milan, Italy; IRCCS Ospedale Galeazzi-Sant'Ambrogio, Milan, Italy; Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA
1 shared publication - Fabrizio Ceresa
Cardio-Vascular and Thoracic Department, Papardo Hospital, 98158 Messina, Italy
1 shared publication - Federico Ranocchi
Department of Cardiac Surgery, Sant’Andrea Hospital, “Sapienza” University, Via di Grottarossa, 1035 Rome, Italy
1 shared publication
Latest Publications
- Open Access
- 30 July 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (15) , 4471
SURgical vs. PERcutaneous ACCESS in Transfemoral Transcatheter Aortic Valve Implantation (SU-PER-ACCESS Study)
Background: The transfemoral (TF) approach is the most common route in TAVI, but it is still associated with a risk of bleeding and vascular complications. The aim of this study was to compare the clinical outcomes between surgical cut-down (SC) and percutaneous (PC) approach. (2) Methods: Between January 2018 and June 2022, 774 patients underwent a transfemoral TAVI procedure. After propensity matching, 323 patients underwent TAVI in each group. (3) Results: In the matched population, 15 patients (4.6%) in the SC group vs. 34 patients in the PC group (11%) experienced minor vascular complications (p = 0.02), while no difference for major vascular complication (1.5% vs. 1.9%) were reported. The rate of minor bleeding events was higher in the percutaneous group (11% vs. 3.1%, p <.001). The SC group experienced a higher rate of non-vascular-related access complications (minor 8% vs. 1.2%; major 2.2% vs. 1.2%; p < 0.001). (4) Conclusions: SC for TF-TAVI did not alter the mortality rate at 30 days and was associated with reduced minor vascular complication and bleeding. PC showed a lower rate of non-vascular-related access complications and a lower length of stay. The specific approach should be tailored to the patient’s clinical characteristics.
- 30 July 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (15) , 4471
Open AccessSURgical vs. PERcutaneous ACCESS in Transfemoral Transcatheter Aortic Valve Implantation (SU-PER-ACCESS Study)
Background: The transfemoral (TF) approach is the most common route in TAVI, but it is still associated with a risk of bleeding and vascular complications. The aim of this study was to compare the clinical outcomes between surgical cut-down (SC) and percutaneous (PC) approach. (2) Methods: Between January 2018 and June 2022, 774 patients underwent a transfemoral TAVI procedure. After propensity matching, 323 patients underwent TAVI in each group. (3) Results: In the matched population, 15 patients (4.6%) in the SC group vs. 34 patients in the PC group (11%) experienced minor vascular complications (p = 0.02), while no difference for major vascular complication (1.5% vs. 1.9%) were reported. The rate of minor bleeding events was higher in the percutaneous group (11% vs. 3.1%, p <.001). The SC group experienced a higher rate of non-vascular-related access complications (minor 8% vs. 1.2%; major 2.2% vs. 1.2%; p < 0.001). (4) Conclusions: SC for TF-TAVI did not alter the mortality rate at 30 days and was associated with reduced minor vascular complication and bleeding. PC showed a lower rate of non-vascular-related access complications and a lower length of stay. The specific approach should be tailored to the patient’s clinical characteristics.
- 18 November 2022
- Published by Springer Nature
- p. 35-45
CABG Should Be the First Option for Left Main Disease: A Cardiac Surgeon’s Perspective
- 18 November 2022
- Published by Springer Nature
- p. 35-45
CABG Should Be the First Option for Left Main Disease: A Cardiac Surgeon’s Perspective